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Objectives: To gain a more detailed understanding of endogenous (mutational) and exogenous (horizontally
acquired) resistance to silver in Gram-negative pathogens, with an emphasis on clarifying the genetic bases
for resistance.
Methods: A suite of microbiological and molecular genetic techniques was employed to select and characterize
endogenous and exogenous silver resistance in several Gram-negative species.
Results: In Escherichia coli, endogenous resistance arose after 6 days of exposure to silver, a consequence of two
point mutations that were both necessary and sufficient for the phenotype. These mutations, in ompR and cusS,
respectively conferred loss of the OmpC/F porins and derepression of the CusCFBA efflux transporter, both pheno-
typic changes previously linked to reduced intracellular accumulation of silver. Exogenous resistance involved
derepression of the SilCFBA efflux transporter as a consequence of mutation in silS, but was additionally contin-
gent on expression of the periplasmic silver-sequestration protein SilE. Silver resistance could be selected at high
frequency (.1029) from Enterobacteriaceae lacking OmpC/F porins or harbouring the sil operon and both
endogenous and exogenous resistance were associated with modest fitness costs in vitro.
Conclusions: Both endogenous and exogenous silver resistance are dependent on the derepressed expression of
closely related efflux transporters and are therefore mechanistically similar phenotypes. The ease with which
silver resistance can become selected in some bacterial pathogens in vitro suggests that there would be benefit
in improved surveillance for silver-resistant isolates in the clinic, along with greater control over use of silver-
containing products, in order to best preserve the clinical utility of silver.
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Introduction
The silver cation (Ag+) has for centuries been employed as an anti-
microbial agent. Current medical uses of silver include the preven-
tion and treatment of bacterial infection in burns and chronic
wounds;1,2 in 2009 alone, the UK National Health Service spent
£25 million on silver-containing dressings for these purposes.3
In recent years, silver has also gained popularity outside of the
clinic for its antimicrobial properties and is routinely incorporated
into a variety of domestic and personal products, including paints,
deodorants and clothing.4,5
The increasing use of silver for medical and non-medical appli-
cations has raised concerns that bacterial resistance to silver
might proliferate in a manner analogous to that seen for antibio-
tics and thereby compromise its clinical utility.6 In a recent study
to investigate potential silver resistance in the important
Gram-positive pathogen Staphylococcus aureus, we found no evi-
dence for extant resistance in a large collection of clinical
staphylococcal isolates that included 876 strains of S. aureus,
nor could any reduction in silver susceptibility be selected upon
extended passage (42 days) of S. aureus in the presence of silver
in vitro.7 Thus, it appears that the activity of silver is not under
imminent threat from resistance in the staphylococci. However,
growing silver usage could prompt a silver resistance problem in
Gram-negative pathogens, particularly since silver resistance is
already known to exist in several such species.8–12
Exogenous (horizontally acquired) silver resistance in Gram-
negative bacteria was first encountered in a strain of Salmonella
Typhimurium that caused an outbreak on a burns ward in 1975
and resulted in the death of three people.8 The genes responsible
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for silver resistance were subsequently mapped to a 14.2 kb
region of the plasmid (pMG101) carried by this strain and have col-
lectively been designated the sil operon.13 The sil operon com-
prises nine ORFs, seven of which are apparently structural genes
(silE, silC, silF, silB, silA, ORF105 and silP) and two of which (silR
and silS) encode a putative two-component regulatory circuit
(Figure 1).13,14 To date, only the function of SilE, a periplasmic
silver-binding protein, has been determined.13 However, based
on amino acid sequence similarity with other heavy metal resist-
ance determinants (e.g. the Pco and Czc systems), the proteins
encoded by the sil operon are believed tomediate silver resistance
by restricting the accumulation of silver in the cell through a com-
bination of silver sequestration in the periplasm (via SilE and SilF
binding) and active efflux [via the resistance-nodulation-division
(RND)-type efflux transporter SilCBA and the putative P-type
ATPase transporter SilP],13,14 as detailed in Figure 1.
In addition to exogenous silver resistance, endogenous (muta-
tional) resistance to silver has been reported in Gram-negative
bacteria under laboratory conditions. Li et al.12 described the
selection of five Escherichia coli mutants exhibiting ≥64-fold
reductions in silver susceptibility compared with the parent strain.
All five strains demonstrated loss of expression of one or more
outer membrane porins (OmpF or OmpF/C), which apparently
resulted in reduced outer membrane permeability, findings
which imply that reduced silver susceptibility might in part result
from restricted silver ingress into the cell. In addition, these strains
were found to exhibit active efflux of silver out of the cell.12
Subsequent studies implicated CusCFBA (Figure 1) as the transporter
responsible for silver efflux; components of the cus operon (CusF
and CusB) were found to be overexpressed in an endogenously
silver-resistant strain15–17 and deletion of cusF in this strain led to
loss of the resistance phenotype.15
Whilst there is therefore some appreciation of the basis for both
endogenous and exogenous silver resistance in Gram-negative
bacteria, both systems remain incompletely characterized. As
part of ongoing work to better understand the phenomenon of sil-
ver resistance in bacterial pathogens and its potential impact on
the clinical utility of silver, we sought in the present study to gain
a more detailed understanding of both types of Gram-negative sil-
ver resistance, with particular emphasis on clarifying their gen-
etic bases.
Methods
General aspects
The bacterial strains and plasmids used in this studyare described in Table 1.
Bacteriawere routinely cultured usingMueller–Hinton broth (MHB) and agar
(Oxoid, Cambridge, UK), although LB broth and agar (Oxoid) were used to
grow strains for genetic manipulation. Antimicrobial agents, including silver
in the form of silver nitrate (AgNO3), and laboratory chemicals were from
Sigma–Aldrich (Poole, UK).
Susceptibility determinations and selection/phenotypic
characterization of silver-resistant strains
MICs of AgNO3 were determined by serial dilution in MHB according to the
CLSI brothmicrodilutionmethod.7,18 The frequency of spontaneousmuta-
tion to silver resistancewas assessed essentially as described previously.19
Passage experiments to select silver-resistant mutants were performed
either by continuous exposure to subinhibitory concentrations of AgNO3
Figure 1. Comparison of the Sil and Cus systems and their proposed role in silver resistance. At the top of the figure, the genetic architecture of the sil and
cus operons is shown; below that is a diagrammatic summary of what is known or predicted regarding the organization and function of these systems.
The sensor kinase, CusS, responds to binding of Ag+ or Cu+ ions by phosphorylating the response regulator, CusR. Phosphorylated CusR mediates
derepression of expression of CusCFBA. CusCBA is an RND-type Ag+/Cu+ efflux transporter that exports Ag+/Cu+ from the periplasm via an antiport
mechanism, whereas CusF is a periplasmic Ag+/Cu+-binding protein that chaperones Ag+/Cu+ to CusCBA for subsequent efflux. Based on sequence
identity, SilCFBA and SilRS are believed to have a similar function to their Cus counterparts. The Sil system includes some additional components not
present in the Cus system: SilE is a periplasmic Ag+-binding protein, SilP is a hypothetical transporter of the P-type ATPase family and no putative function
has been assigned to hypothetical protein ORF105. Dashed lines represent proposed interactions of Ag+/H+ with Sil system components.
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using the extended-gradient MIC method7 or by repeated exposure to
supra-MIC concentrations of AgNO3, in a manner analogous to that
described by Miller et al.20 The relative fitness of silver-resistant strains
was determined by pairwise competition with the parent strain from
which they were derived.21
Whole-genome DNA sequence determination
A sample (1 mg) of total DNA from E. coli J53 (pMG101) was subjected to
DNA sequence determination using the Illumina MiSeq platform at the
Leeds Clinical Molecular Genetics Centre (St James’ Hospital, University
of Leeds). De novo assembly of sequence reads was performed using
CLC Genomics Workbench, version 6 (CLC Bio, Cambridge, MA, USA) and
annotated using the NCBI Prokaryotic Genomes Automatic Annotation
Pipeline (PGAAP). The DNA sequence data for E. coli J53 (pMG101) have
been deposited under GenBank accession number ASRI00000000.
DNA manipulation
PCR was performed using Phusion polymerase (New England Biolabs,
Hertfordshire, UK) in accordance with the manufacturer’s instructions,
Table 1. Bacterial strains and plasmids used in this study
Strain/plasmid Comments Reference/source
E. coli strains
E. coli BW25113 derivative of E. coli K-12 strain BD792 (lacIq rrnBT14
DlacZWJ16 hsdR514 DaraBADAH33 DrhaBADLD78)
24
BW25113 DompC 24
BW25113 DompF 24
BW25113 DompR 24
BW25113 ompRG596A this study
BW25113 cusSG1130A this study
BW25113 ompRG596A cusSG1130A this study
BW25113 ompRG596A cusSG1130A DcusC this study
BW25113 ompRG596A cusSG1130A DcusF this study
BW25113 ompRG596A cusSG1130A DcusB this study
BW25113 ompRG596A cusSG1130A DcusA this study
E. coli J53 (pMG101) silver-resistant E. coli K-12-J53 strain
carrying plasmid pMG101
National Collection of
Type Cultures
J53 (pMG101) DblaZ as above, but with deletion of blaZ on pMG101 this study
J53 (pMG101) DblaZ DsilE this study
J53 (pMG101) DblaZ DsilC this study
J53 (pMG101) DblaZ DsilF this study
J53 (pMG101) DblaZ DsilB this study
J53 (pMG101) DblaZ DsilA this study
J53 (pMG101) DblaZ DsilG this study
J53 (pMG101) DblaZ DsilP this study
J53 (pMG101) DblaZ DsilGP this study
J53 (pMG101) DblaZ DcusSRCFBA this study
J53 (pMG101) DblaZ DcusSRCFBA DsilF this study
J53 (pMG101) DblaZ DcusSRCFBA DsilA this study
J53 (pMG101) DblaZ DcusSRCFBA DsilG this study
J53 (pMG101) DblaZ DcusSRCFBA DsilP this study
J53 (pMG101) DblaZ DcusSRCFBA DsilGP this study
E. coli DY441 source of cat-sacB counterselection marker 22
Other bacterial strains
E. cloacae ATCC 13047 ATCC
K. pneumoniae clinical isolate Leeds General Infirmary
S. sonnei clinical isolate Leeds General Infirmary
C. freundii ATCC 8090 ATCC
Plasmids
pKD4 source of FRT-kanR-FRT marker 40
pCP20 encodes FLP recombinase, ampicillinR, chloramphenicolR 40
pSIM6 encodes l red recombineering system, ampicillinR 23
pSIM18 encodes l red recombineering system, hygromycinR 23
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and DNA sequence determination of PCR amplicons was performed by
Beckman Coulter Genomics (Essex, UK).
Mutagenesis or deletion of genes was performed by recombination-
mediated genetic engineering (recombineering) as described previously.22
Red recombination proteins were expressed from plasmids pSIM6 and
pSIM18 in E. coli BW25113 and E. coli J53 (pMG101), respectively.23 For
individual deletion of genes cusC, cusF, cusB and cusA in E. coli, the corre-
sponding deletion mutants from the Keio collection24 were used as a
source of the FRT-kan-FRT cassette. For all other gene deletions, plasmid
pKD4 was used as the source of FRT-kan-FRT, which was amplified by
PCR using the oligonucleotide primers listed in Table S1 (available
as Supplementary data at JAC Online). Markerless deletions were subse-
quently generated by removal of the FRT-kan-FRT cassette from the site
of integration by the FLP recombinase present on plasmid pCP20. Since
pCP20 requires ampicillin selection for its maintenance, we used recombi-
neering to first delete the native blaZ gene (conferring ampicillin resist-
ance) from E. coli J53 (pMG101) prior to performing all other genetic
manipulations. Allelic replacement mutagenesis of cusS and ompR was
performed with cat-sacB counterselection.22
Expression of SilE in BW25113 cusSG1130A was achieved from the lac
promoter on plasmid pUC18. The silE gene was PCR amplified from
E. coli J53 (pMG101) using oligonucleotide primers (Table S1) that con-
tained engineered SacI (forward primer) and HindIII (reverse primer)
restriction sites at their 5′ ends. The resulting amplicons were digested
with SacI/HindIII, ligated into similarly digested pUC18 and introduced
by transformation into E. coli DH5a, before recovery and transformation
of BW25113 cusSG1130A.
Analysis of cusC expression
RNA extraction, cDNA synthesis and quantitative (q) RT–PCR of cusC and
16S rRNA (internal control) were carried out as described previously,25
with the exception that first-strand cDNA synthesis was performed using
the Omniscript RT kit (Qiagen) with oligo-dT(15) primers and RNase inhibi-
tor (Promega) at final concentrations of 1 mM and 10 U, respectively.
qRT–PCR was performed in an MxPro Mx3005P thermocycler (Agilent,
Wokingham, UK) using the Quantifast SYBR Green PCR kit (Qiagen).
Results
Endogenous resistance to silver
Selection for endogenous resistance to silver
Attempts to select endogenous resistance to silver in E. coli strain
BW25113 by plating saturated cultures onto agar containing sil-
ver at concentrations above the MIC (4 mg/L AgNO3) were unsuc-
cessful (limit of detection ,1×10210). By contrast, endogenous
resistance could be selected in BW25113 upon serial passage in
the presence of sub-MIC concentrations of AgNO3 using the
extended-gradient MIC method described previously.7 In three
independent selections, a strain resistant to .256 mg/L AgNO3
arose on day 6 of the passage experiment. Attempts were also
made to select resistance by repeated exposure of BW25113 to
suprainhibitory concentrations of AgNO3 (40, 80 or 100 mg/L);
however, after 42 days no reductions in silver susceptibility
could be selected under these conditions.
Endogenous silver resistance results from two independent
mutational events
Endogenous silver resistance in E. coli has been associated with
loss of porins from the outer membrane and up-regulation of
the native Cus efflux mechanism that is capable of transporting
silver out of the cell.12,15 The genetic basis for these phenotypes
is unknown and it has not been established whether they are
necessary or sufficient to bring about resistance to silver. To iden-
tify the genetic changes that could underlie these phenotypes in
our silver-resistant mutants, we subjected the following genes to
PCR amplification and DNA sequencing: ompF, ompC and ompA
(encoding the three major porins), ompR and envZ (encoding reg-
ulators of porin expression) and cusR and cusS (encoding regula-
tors of expression of the CusCFBA efflux transporter). All three
silver-resistant mutants harboured mutations in both ompR and
cusS; all carried the same missense mutation G596A in ompR
(encoding amino acid substitution R199H), but distinct missense
mutations in cusS (T638G, C935A and G1130A, encoding I213S,
A312E and R377H, respectively). To establish whether these
mutations were both necessary and sufficient for the silver resist-
ance phenotype, we used recombineering to reintroduce
ompRG596A and cusSG1130A, alone and in combination, into E. coli
BW25113. Individually, neither mutation conferred an increase in
the AgNO3 MIC compared with E. coli BW25113 (data not shown).
However, when both mutations were introduced into the same
strain, silver resistance (MIC .256 mg/L AgNO3) was observed.
Emergence and maintenance of endogenous silver
resistance
We sought to establish which of the two mutations in our silver-
resistant mutants had arisen first, an approach made possible by
the fact that samples of cultures from each day of the passage
experiment had been stored. PCR amplification and DNA sequence
determination of the ompR and cusS genes from daily cultures
recovered from all three independent passage experiments
revealed that the mutation in ompR arose first after 4–5 days,
whereas mutations in cusS arose on day 6. Although the ompR
mutation did not affect gross silver susceptibility in standard MIC
determinations, it presumably became selected because it none-
theless conferred a modest growth advantage over the parent
strain BW25113 in the presence of silver. This was confirmed by
evaluating the growth characteristics of BW25113 and BW25113
ompRG596A in the presence of 2 mg/L AgNO3 (Figure 2). Under
these culture conditions, a prolonged lag phase (15 h)was observed
for BW25113, whereas BW25113 ompRG596A entered the exponen-
tial phase of growth after only 7 h. We also assessed the ability of
mutation in cusS associated with silver resistance (cusSG1130A) to
confer a growth advantage in the presence of a sub-MIC concentra-
tion of AgNO3. Although amodest growth advantagewas observed,
it was less than that observed for strains carrying the silver
resistance-associated mutation in ompR (Figure 2), thereby provid-
ing an explanation for the observed order in which the mutations in
ompR and cusS arose under silver selection.
Experiments monitoring bacterial growth in the presence of a
sub-MIC concentration of AgNO3 also revealed that BW25113
ompRG596A and a strain deleted for ompR (BW25113 DompR)
demonstrated a comparable growth advantage over BW25113
(Figure 2), suggesting that the silver resistance-associated muta-
tion in ompR causes loss of function of the OmpR protein. This
was anticipated; OmpR is a transcriptional activator known to be
required for expression of both OmpC and OmpF porins26 and
only loss of function of this protein would be expected to reduce
outer membrane permeability to silver by causing loss of porin
Randall et al.
1040
expression. We confirmed through SDS–PAGE analysis of mem-
brane fractions that neither OmpF nor OmpC was expressed in
BW25113 ompRG596A (data not shown).
Since genetic changes leading to loss of porin expression
represent the initial event in the selection of endogenous silver
resistance in E. coli in vitro, we reasoned that silver resistance
would arise more rapidly in strains lacking porins prior to silver
exposure, i.e. such strains would be primed for the development
of endogenous silver resistance. Plating of saturated cultures of
BW25113 DompR (deficient in expression of both OmpC and
OmpF) onto agar containing AgNO3 at 4×MIC recovered mutants
exhibiting silver resistance (AgNO3 MIC .256 mg/L) at a fre-
quency of 9.2+1.2×1028. The high frequency with which silver-
resistant mutants arose is indicative of a single mutational
event and PCR amplification and DNA sequencing of a selection
of silver-resistant derivatives of BW25113 DompR mapped the
resistance mutation to cusS in all cases (data not shown). By con-
trast, silver resistance could not be selected under identical con-
ditions using strains BW25113 DompF and BW25113 DompC, a
result implying that both the OmpC and OmpF porins must be
lacking to allow silver resistance tomanifest. E. coli isolates lacking
OmpC/F porins are extant in the clinic, often selected by exposure
to b-lactam antibiotics.27 To ascertain if silver resistance can
occur readily in such strains, we determined silver resistance
mutation frequencies for E. coli EC18,28 a clinical isolate deficient
in OmpC/F. A mutation frequency of 7.5+0.9×1028 was recorded
at a selecting AgNO3 concentration of 4× MIC, with mutants
resistant to .256 mg/L AgNO3.
To provide an indication of the diversity of mutations within
cusS and ompR that can participate in silver resistance, saturated
cultures of strains E. coli BW25113 cusSG1130A and BW25113
ompRG596A were plated onto agar containing AgNO3 at 4×MIC.
The DNA sequences of ompR and cusS were determined from at
least four independent silver-resistant mutants arising from
each strain. Mutations in ompR contributing to resistance included
a nonsense mutation (C88T) and missense mutations encoding
amino acid substitutions R199H and Q204P, both of which
mapped within the C-terminal domains of OmpR (Figure 3). In
the case of cusS, mutations conferring resistance led to amino
acid substitutions that were not localized within any particular
region of CusS, but were instead distributed along the length of
the protein (T17P, I213S, A312E, A351E and R377H).
Endogenous silver resistance in E. coli has to date only been
encountered under laboratory conditions; whether it occurs in
the clinic is unknown. The observation that endogenous resist-
ance can arise through two point mutations, or via a single
point mutation in strains lacking OmpC/F porins, suggests that it
could occur clinically under conditions of silver selection. To
provide a further evaluation of the likelihood for endogenously
silver-resistant E. coli to arise, survive and proliferate in the clinical
environment, we determined the fitness cost associated with the
Figure 2. Growth of E. coli BW25113 and derivatives carrying mutations
associated with endogenous silver resistance in the presence of 2 mg/L
AgNO3. Open diamonds, BW25113; filled squares, BW25113 ompRG596A;
open triangles, BW25113 DompR; filled circles, BW25113 cusSG1130A.
Figure 3. Amino acid substitutions in the OmpR protein that contribute to
endogenous silver resistance in E. coli. Residues 138–233 of OmpR are
shown, a portion of the protein that comprises a winged helix-turn-helix
(PDB accession 10DD, originally presented by Kondo et al.41). The a3
helix of this domain (residues 200–13; highlighted blue) is responsible
for DNA recognition and binding, whilst the ‘turn’ region (residues 191–
99; highlighted yellow) within this domain recruits RNA polymerase to
the site of OmpR–DNA interaction, allowing for transcription of genes
including ompC and ompF.41,42 Amino acid substitution Q204P is located
within the a3 helix, whilst R199H lies within the turn region; these
substitutions likely mediate loss of function in OmpR by disrupting the
ability of OmpR to bind DNA and to recruit RNA polymerase, respectively.
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silver resistance phenotype. Pairwise competition experiments
with BW25113 and BW25113 ompRG596A cusSG1130A established
a relative fitness value of 0.71+0.02 for the latter, indicating a
reduction in competitive fitness compared with the parent strain.
However, since antibacterial resistance genotypes associated
with greater reductions in in vitro competitive fitness than this
have been isolated from patients,29 it seems unlikely that this
degree of fitness impairment would represent a significant barrier
to the emergence and spread of endogenous silver resistance in
the clinical environment.
Silver resistance mutations in CusS derepress expression
of CusCFBA, an efflux transporter that is essential for
endogenous silver resistance
The CusRS two-component system is a positive regulator of the
CusCFBA efflux transporter.30 Mutations in cusS participating in
endogenous silver resistance presumably promote gain of func-
tion in CusS, which in turn leads to elevated expression of
cusCFBA and ultimately to increased Ag+ efflux. To establish the
effect of cusS mutations on expression of the cusCFBA operon,
qRT–PCR was used to determine the relative expression of cusC
in BW25113 and in the silver-resistant derivative BW25113
ompRG596A cusSG1130A, in the absence of silver. The silver-resistant
strain exhibited 6.2+0.3-fold greater expression of the cus operon
relative to the parental strain. Thus, mutations in cusS participat-
ing in silver resistance do result in gain of function and silver resist-
ance is associated with elevated expression of cusCFBA.
Although CusF has previously been shown to be essential for
endogenous silver resistance in E. coli,15 the essentiality of the
CusCBA efflux transporter for silver resistance has not been estab-
lished. To examine this, we independently deleted the genes
encoding CusC, CusB and CusA in the silver-resistant strain
BW25113 ompRG596A cusSG1130A. Irrespective of the component
deleted, the silver resistance phenotype was lost, with all three
strains demonstrating an equivalent susceptibility to silver
(4 mg/L) as the silver-susceptible parent strain BW25113.
Failure to select endogenous silver resistance in other
Gram-negative genera harbouring the Cus system
The Cus system is not unique to E. coli. BLAST searching conducted
during the present study revealed that it exists within a number of
other medically important Gram-negative species, including
Citrobacter freundii and Shigella sonnei. To determine whether
endogenous silver resistance can also arise in these organisms,
we subjected C. freundii ATCC 8090 and a clinical isolate of S. sonnei
to continuous passage in the presence of sub-MIC concentrations
of AgNO3, exactly as described above for E. coli. No reduction in sil-
ver susceptibility was detected in either strain after 42 days of con-
tinuous passage in the presence of silver, indicating that the
presence of the cus operon in an organism’s genome is not alone
sufficient to ensure the emergence of endogenous silver resistance.
Exogenous resistance to silver
DNA sequencing of E. coli J53 (pMG101) and sequence
analysis of the sil operon
As mentioned above, plasmid pMG101 from Salmonella
Typhimuriumwas the original source of the siloperon characterized
by Gupta et al.13 This plasmid is a member of the IncH incompati-
bility group and in addition to silver resistance has been shown
to confer resistance to ampicillin, chloramphenicol, mercury,
streptomycin, sulphonamides and tetracycline.8,31 Although the
nucleotide sequence of the region of plasmid pMG101 containing
the sil operon has previously been determined (GenBank accession
number AF067954), DNA sequence determination in our own
laboratory of several sil operon components on pMG101 revealed
some discrepancies. Consequently, we decided to resequence the
sil operon and to generate, for the first time, DNA sequence infor-
mation for the remainder of the pMG101 plasmid. To achieve this,
we performed sequencing of total DNA recovered from E. coli strain
J53 (pMG101). Following Illumina sequencing and de novo assem-
bly, 113 contiguous sequenceswere obtained (with anN50 value of
103568), of which 105 aligned to the previously deposited genome
sequence of E. coli J53 lacking the pMG101 plasmid (GenBank
accession number AICK00000000). The remaining eight contigs,
comprising 151 kb of DNA sequence that did not align to the
E. coli J53 sequence but that exhibited homology with other
sequenced plasmids found in Salmonella species, represented plas-
mid pMG101. The DNA sequence of E. coli J53 (pMG101) has been
deposited in GenBank under accession number ASRI00000000.
As described above, plasmid pMG101 confers resistance to a
range of antimicrobial agents in addition to silver.8 The nucleotide
sequence of pMG101 determined here revealed the basis for each
of these resistance phenotypes: resistance to sulphonamides,mer-
cury, streptomycin, ampicillin, chloramphenicol and tetracycline is
mediated, respectively, by a sulphonamide-insusceptible FolP
(locus tag L670_22583), the Mer system (L670_22518-22538), a
streptomycin 3′-adenylyltransferase (L670_22593), a class D
(OXA) b-lactamase (L670_22598), a chloramphenicol acetyltrans-
ferase (L670_22638) and TetA (L670_22816). Unexpectedly, the sil
operon in E. coli J53 (pMG101) was found not to reside on pMG101,
but had instead become integrated into the chromosome along
with the copper resistance operon pco. Integration of the sil and
pco operons into the chromosome from pMG101 appears to have
been mediated by Tn7-based transposition, given the presence of
Tn7-like elements in the integrant directly upstream of the sil
operon. To calculate the approximate size of the original pMG101
plasmid with the sil and pco operons, the sizes of all eight contigu-
ous sequences corresponding with pMG101 were added to the size
of the integrated pMG101 fragment. This gave a total size for
pMG101 of 183.5 kb, a figure close to the 180 kb estimate pro-
vided previously by Gupta et al.13
Comparison of the nucleotide sequence of the sil operon
obtained in this study with the previously determined sequence
(GenBank accession number AF067954) identified numerous dis-
crepancies between the two. That these were not the result of
DNA sequencing errors in the present study was confirmed by
PCR and DNA sequencing of relevant regions of the sil operon
from E. coli J53 (pMG101) (data not shown). In summary, 51 dif-
ferences were identified between the two nucleotide sequences,
comprising 10 base changes, 13 insertions and 28 deletions. Of
these, 40 resulted in changes to the predicted amino acid
sequence of Sil system components (Figure 4). In addition, the
PGAAP algorithm used in this study to assign ORFs suggested
start codons for silF, silPandORF105 different from those originally
assigned by Gupta et al.13 and which, if correct, would alter the
predicted amino acid length of the protein products encoded by
these genes (SilF, from 96 to 117 amino acids; SilP, from 824 to
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815 amino acids; and ORF105, from 105 to 146 amino acids). We
havemade the assumption in Figure 4 that the PGAAPassignment
is more likely to be correct; however, experimental studies will
ultimately be required to confirm these predictions.
The sil operon contains an ORF between silA and silP, desig-
nated ORF105 in the original sequence submission, which appears
to encode a protein for which not even a putative function has
been assigned (Figure 1). BLAST searching with the encoded
amino acid sequence of ORF105 identified several homologous
proteins in GenBank with sequence identities of 45%. These
homologues included a putative copper chaperone termed CopG
from Cupriavidusmetallidurans32 and both CopG and ORF105 con-
tain a conserved CxxC motif that is known to be involved in metal
binding (Figure 5).33 ORF105 may therefore represent a metal
chaperone. Bioinformatic analysis of this protein using the
SignalP 4.0 server (http://www.cbs.dtu.dk/services/SignalP/)34
identified a putative N-terminal signal peptide, suggesting that,
as for other components of the Sil system, this protein is localized
in the periplasm (data not shown). Given the similarity of the gene
product of ORF105 to CopG, we propose that the former is
renamed silG both to acknowledge this fact and to maintain the
nomenclature of the sil operon.
Role of Sil system components in silver resistance
Whether all of the components encoded by the sil operon are
required to mediate silver resistance has not been established.
To address this question, we constructed a series of deletion
mutants of E. coli J53 (pMG101) in which each of the sil genes
was independently deleted and assessed the effect that this
had on silver susceptibility (Table 2). Deletion of silC, silB, silA or
silE led to complete loss of silver resistance, with the MIC of
AgNO3 decreasing from .256 to 4–8 mg/L. By contrast, deletion
of silF, silP or silG had no, or only limited, effect on the silver resist-
ance phenotype (Table 2). Since the Sil and the Cus systems are
homologous, and since E. coli J53 (pMG101) contains the cus
operon as part of its genome, we considered the possibility that
Cus system components could potentially act to complement for
loss of SilF, SilP or SilG. By deleting the entire cus operon from
E. coli J53 (pMG101), we found that this does appear to be the
case for SilF; in the cus-negative background, deletion of silF resulted
in complete loss of silver resistance (Table 2). By contrast, deletion
of silP or silG in the cus-negative background, individually or in com-
bination, had no detectable effect on the MIC of AgNO3 (Table 2).
Despite the similarity of the Cus and Sil efflux transporters, only
the latter system mediates silver resistance without the require-
ment for loss of porins from the outer membrane. Since SilE is the
only protein of the Sil systemessential for silver resistance that does
not have a direct counterpart in the Cus system, it seemed probable
that SilE acts to augment the action of the SilCFBA transporter,
thereby obviating the need for porin loss. To provide confirmation
for this, we examined whether SilE could also augment the action
of the CusCFBA transporter, to bring about Cus-mediated silver
resistance without porin loss. Introduction of pUC18:silE into
BW25113 cusSG1130A established that indeed it could, with the
MIC of AgNO3 increasing from 4 to .256 mg/L.
Sil-based silver resistance in other bacterial genera
We established through BLAST searching that a number of other
medically important Gram-negative species harbour the silFi
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operon, including strains of Enterobacter cloacae and Klebsiella
pneumoniae. To examine whether this operon also confers silver
resistance in these species, the MICs of AgNO3 for E. cloacae
ATCC 13047 and a clinical isolate of K. pneumoniae were deter-
mined. For both strains, AgNO3 had an MIC of 4 mg/L, a level of
susceptibility equivalent to that seen for E. coli strains lacking
the sil operon (i.e. fully silver susceptible). As established above
for the cus operon, it may be that derepression of expression of
the sil operon is required for silver resistance to manifest.
Indeed, in a previous study, expression of the sil operon on
pMG101 was shown to be constitutively high in comparison with
that resident on other IncH plasmids that did not confer silver
resistance.31 In an attempt to select spontaneous silver-resistant
mutants of E. cloacae and K. pneumoniae in which expression of
the sil operon had become derepressed, saturated cultures of
these strains were plated onto agar containing AgNO3 at 4×
MIC. For both strains, mutants exhibiting silver resistance (MIC
.256 mg/L AgNO3) were recovered at frequencies suggestive of
a single mutational event (1.9+0.9×1028 and 3.4+1.7×1028
for E. cloacae and K. pneumoniae, respectively). PCR amplification
and DNA sequence determination of the silS gene from a single
silver-resistant mutant of E. cloacae and K. pneumoniae identified
mutations C638A (encoding amino acid change P213H) and
G304A (encoding amino acid change A102T), respectively. Silver
resistance mediated by the Sil system had minimal impact on
bacterial fitness, resulting in a relative fitness of 0.91+0.04 and
0.98+0.02 for silver-resistant E. cloacae and K. pneumoniae,
respectively, when compared with their silver-susceptible paren-
tal strains.
Discussion
Our current understanding of the antibacterial mode of action of
silver is that it is mediated predominantly through perturbation of
the bacterial cytoplasmic membrane.7 In view of this, it is unsur-
prising that both endogenous and exogenous resistance to silver
in Gram-negative bacteria involve mechanisms that act to restrict
the accumulation of silver in the periplasm, since this will serve to
limit the amount of silver reaching its antibacterial target. An
essential component of both endogenous and exogenous
resistance is silver efflux, mediated by the CusCFBA transporter
in the case of endogenous resistance in E. coli and the SilCFBA
transporter in exogenous resistance. These transporters are
closely related homologues, with most of the counterpart pro-
teins from the CusCFBA and the SilCFBA systems exhibiting
amino acid sequence identities of .80% (data not shown).
Furthermore, we have demonstrated here that SilE is able to aug-
ment the silver resistance phenotype associated with the
CusCFBA transporter and that CusF is apparently able to comple-
ment for loss of SilF, findings that imply functional overlap
between the two systems. The crystal structures of the CusCBA
transporter and CusF have recently been solved16,35,36 and reveal
that CusCBA utilizes a methionine shuttle to transport Ag+ and
Cu+ out of the cell, whilst CusF utilizes cation–p and methionine
interactions to bind a single Ag+ or Cu+ ion for delivery to CusCBA
and subsequent efflux.16,17,37,38 In view of the high degree of pri-
mary sequence identity and the functional overlap between the Sil
and Cus transporters, it seems highly likely that SilCFBA operates
Figure 5. Alignment of the ORF105 protein from E. coli J53 (pMG101) with CopG proteins from various bacterial species. The conserved CxxC
metal-binding motif is indicated. ORF105 has been redesignated SilG (please refer to the text).
Table 2. Silver susceptibility of E. coli J53 (pMG101) strains deleted for Sil
and Cus system components
Strain Silver nitrate MIC (mg/L)
J53 (pMG101) .256
J53 (pMG101) DblaZ .256
J53 (pMG101) DblaZ DsilE 4
J53 (pMG101) DblaZ DsilC 4
J53 (pMG101) DblaZ DsilF 128
J53 (pMG101) DblaZ DsilB 4
J53 (pMG101) DblaZ DsilA 8
J53 (pMG101) DblaZ DsilG .256
J53 (pMG101) DblaZ DsilP .256
J53 (pMG101) DblaZ DsilGP .256
J53 (pMG101) DblaZ DcusSRCFBA .256
J53 (pMG101) DblaZ DcusSRCFBA DsilF 8
J53 (pMG101) DblaZ DcusSRCFBA DsilG .256
J53 (pMG101) DblaZ DcusSRCFBA DsilP .256
J53 (pMG101) DblaZ DcusSRCFBA DsilGP .256
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in the samemanner. Thus, whilst endogenous and exogenous sil-
ver efflux in E. coli are genetically distinct phenomena, they appar-
ently involve closely related mechanisms.
Expression of the Cus and Sil system efflux transporters is regu-
lated in each case by a cognate two-component system (CusRS
and SilRS, respectively) (Figure 1).30,31 In the absence of a stimulus
(shown experimentally to be Cu+ or Ag+ ions for CusS and Ag+ for
SilS), expression of these transporters is ordinarily repressed.30,31
Here, we have shown that in strains displaying a silver resistance
phenotype involving either the Cus or the Sil system, derepression
of transporter expression occurs owing to amino acid substitu-
tions within the cognate sensor kinase (CusS or SilS). Although
derepression of either CusCFBA or SilCFBA transporters is a require-
ment for silver resistance, the resulting increased efflux of silver is
not alone sufficient to achieve an overt resistance phenotype.
Presumably, the maximal rate at which these transporters are
able to efflux silver is barely able to keep pace with the rate of sil-
ver ingress into the periplasm. Consequently, for an overt silver
resistance phenotype to manifest, the effect of silver efflux
must be augmented bymechanisms that act to restrict the accu-
mulation of free silver ions in the periplasm.
In the case of endogenous resistance, this is achieved by
restricting silver ingress as a consequence of loss of outer mem-
brane porins. Although an earlier study using silver-resistant strains
of E. coli selected in vitro suggested that loss of the OmpFporin was
alone sufficient to restrict ingress to a level permitting Cus-
mediated silver resistance,12 our present studies using defined
deletion mutants have shown that OmpC and OmpF must both
be absent. In agreement with this idea, we failed to recover
endogenous silver-resistant mutants carryingmutations in individ-
ual porin-encoding genes. Instead, in all mutants selected, we
observed simultaneous loss of OmpC/F porins as a consequence
of mutation in ompR, the gene encoding the transcription factor
responsible for activating OmpC/F expression.26 There has been
extensive study of the structure and function of the OmpR protein,
allowing us to make predictions as to how the different amino acid
substitutions associated with silver resistance likely affect OmpR to
prevent it from activating the expression of OmpC/F (Figure 3).
In contrast to endogenous silver resistance, exogenous resist-
ance mediated by the Sil system is not contingent upon loss of
outer membrane porins. Here, the effect of silver efflux is instead
augmented by the action of the SilE protein, a concept supported
by several lines of evidence.We have demonstrated that SilE is the
only other Sil system component aside from SilCFBA that is essen-
tial for the exogenous silver resistance phenotype and there is no
direct counterpart to this protein in the Cus system. Furthermore,
engineering E. coli to carry both a derepressed cusCFBA operon
and silE conferred silver resistance, without any requirement for
loss of porins. In contrast to porin loss in endogenous resistance,
which restricts silver ingress to the periplasm, SilE presumably has
no effect on ingress and acts instead to reduce the periplasmic
concentration of silver ions through sequestration.13 However, in
the presence of high silver concentrations, the silver-binding cap-
acity of the SilE protein would likely become exceeded, leading to
silver concentrations in the periplasm reaching toxic levels. We
therefore speculate that SilE does not only sequester silver ions,
but also acts in a manner analogous to SilF/CusF and chaperones
silver to SilCBA for efflux, either directly or via SilF (Figure 1).
The potential for selection of silver resistance in Gram-negative
bacteria varies considerably between species. We failed to select
any reduction in silver susceptibility in Pseudomonas aeruginosa,7
Acinetobacter baumannii (data not shown), C. freundii and
S. sonnei during 42 days of continuous passage in the presence
of AgNO3. By contrast, and under identical selecting conditions,
endogenous resistance to silver (MIC of AgNO3 .256 mg/L)
could be selected in E. coli in just 6 days. Furthermore, in some
fully silver-susceptible Enterobacteriaceae, resistance could be
selected in a single step (i.e. by a single point mutation) from (i)
organisms harbouring a repressed sil operon (e.g. strains of
K. pneumoniae and E. cloacae) or (ii) E. coli strains deficient in
the OmpF/C porins. The frequency with which silver resistance
can arise in some strains is therefore comparable to that
(.1029) seen for antibiotics acting upon a single cellular target,
agents that are usually considered unsuitable for monotherapy
owing to resistance liabilities.39 Furthermore, although both
endogenous and exogenousmechanisms of silver resistance con-
fer a fitness cost in vitro, this is unlikely to be sufficient to present a
significant barrier to the emergence or spread of silver resistance
in the clinic, particularly in settings where silver is in heavy use. The
ease with which silver resistance can arise in vitro in some patho-
genic Gram-negative species suggests that therewould be benefit
in surveillance programmes to monitor the emergence and
spread of silver-resistant isolates, greater control over use of silver
for medical applications and restricted use of antimicrobial silver
for non-medical purposes. Collectively, these measures could
serve to limit the development of resistance and thereby help to
preserve the clinical utility of silver.
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